Immunization coverage surveys and linked biomarker serosurveys in three regions in Ethiopia

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Travassos, Mark A ^a   Beyene, Berhane ^b   Adam, Zenaw ^c   Campbell, James D ^a   Mulholland, Nigisti ^d   Diarra, Seydou S ^e   Kassa, Tassew ^b   Oot, Lisa ^c   Sequeira, Jenny ^c   Reymann, Mardi ^a   Blackwelder, William C ^a   Wu, Yukun ^a   Ruslanova, Inna ^a   Goswami, Jaya ^a   Sow, Samba O ^e   Pasetti, Marcela F ^a   Steinglass, Robert ^c   Kebede, Amha ^b   Levine, Myron M ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^c JSI RESEARCH AND TRAINING INSTITUTE   (United States)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

^e Centre pour le Developpement des Vaccins   (Mali)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G ANTIBODY; TETANUS ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE VACCINE; HAEMOPHILUS VACCINE; IMMUNOGLOBULIN G;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; ETHIOPIA; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH SURVEY; HUMAN; INFANT; INFLUENZA B; INFLUENZA VACCINATION; PREDICTIVE VALUE; SEROLOGY; BACTERIAL CAPSULE; BLOOD; FEMALE; IMMUNIZATION; IMMUNOLOGY; MALE; PARENT; PREVENTIVE HEALTH SERVICE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

BACTERIAL CAPSULES; BIOMARKERS; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; ETHIOPIA; FEMALE; HAEMOPHILUS VACCINES; HEALTH SURVEYS; HUMANS; IMMUNIZATION; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN G; INFANT; MALE; PARENTS; VACCINATION;

EID: 84961266728     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149970     Document Type: Article

References (43)

1. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012 May 10.
2. Bhutta ZA, Black RE. Global maternal, newborn, and child health-so near and yet so far. N Engl J Med 2013 Dec 5; 369(23):2226-35. doi:10.1056/NEJMra1111853 PMID: 24304052.
3. Orenstein WA, Seib K, Graham-Rowe D, Berkley S. Contemporary vaccine challenges: improving global health one shot at a time. Sci Transl Med 2014 Sep 10; 6(253):253-11. doi:10.1126/scitranslmed.3009848 PMID: 25210061.
4. Okwaraji YB, Mulholland K, Schellenberg JR, Andarge G, Admassu M, Edmond KM. The association between travel time to health facilities and childhood vaccine coverage in rural Ethiopia. A community based cross sectional study. BMC Public Health 2012 Jun 22; 12:476. doi:10.1186/1471-2458-12-476.:476-12 PMID: 22726457.
5. UNICEF. State of the World's Children 2012. Children in an Urban World. 1-142. 2012. New Jersey, Hatteras Press.
6. WHO and UNICEF. Ethiopia: WHO and UNICEF estimates of immunization coverage: 2013 revision. 2014.
7. Burton A, Monasch R, Lautenbach B, Gacic-Dobo M, Neill M, Karimov R, et al. WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bull World Health Organ 2009 Jul; 87(7):535-41. PMID: 19649368.
8. Central Statistical Agency EaIICM. Ethiopia Demographic and Health Survey 2011. Calverton, MD: ICF International; 2012 Mar.
9. World Health Organization VAaMTDoIVaB. Immunization coverage cluster survey-Reference manual. 2005. Geneva, WHO Document Production Services.
10. Henderson RH, Sundaresan T. Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. Bull World Health Organ 1982; 60(2):253-60. PMID: 6980735.
11. Cutts FT, Izurieta HS, Rhoda DA. Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys. Plos Med 2013; 10(5):e1001404. doi:10.1371/journal.pmed.1001404 PMID: 23667334.
12. Colson KE, Zuniga-Brenes P, Rios-Zertuche D, Conde-Glez CJ, Gagnier MC, Palmisano E, et al. Comparative Estimates of Crude and Effective Coverage of Measles Immunization in Low-Resource Settings: Findings from Salud Mesoamerica 2015. PLoS ONE 2015 Jul 2; 10(7):e0130697. doi:10.1371/journal.pone.0130697 PMID: 26136239.
13. MacNeil A, Lee CW, Dietz V. Issues and considerations in the use of serologic biomarkers for classifying vaccination history in household surveys. Vaccine 2014 Sep 3; 32(39):4893-900. doi:10.1016/j.vaccine.2014.07.005 PMID: 25045821.
14. Borrow R, Balmer P, Roper MH. Module 3: Tetanus. Update 2006. 1-51. 2007. Geneva, World Health Organization. The Immunological Basis for Immunization Series.
15. Levine MM. "IDEAL" vaccines for resource poor settings. Vaccine 2011 Dec 30; 29 Suppl 4:116-25. doi:10.1016/j.vaccine.2011.11.090.:D116-D125 PMID: 22486974.
16. Sow SO, Tapia MD, Diallo S, Keita MM, Sylla M, Onwuchekwa U, et al. Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection. Am J Trop Med Hyg 2009 Jun; 80(6):1033-8. PMID: 19478272.
17. Hutter J, Pasetti MF, Sanogo D, Tapia MD, Sow SO, Levine MM. Naturally acquired and conjugate vaccine- induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali. Am J Trop Med Hyg 2012 Jun; 86 (6):1026-31. doi:10.4269/ajtmh.2012.11-0807PMID: 22665612.
18. Kayhty H, Peltola H, Karanko V, et al. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983; 147:1100. PMID: 6602191.
19. Chen D, Tyagi A, Carpenter J, Perkins S, Sylvester D, Guy M, et al. Characterization of the freeze sensitivity of a hepatitis B vaccine. Hum Vaccin 2009 Jan; 5(1):26-32. PMID: 18971625.
20. Travassos MA, Beyene B, Adam Z, Campbell JD, Mulholland N, Diarra SS, et al. Strategies for Coordination of a Serosurvey in Parallel with an Immunization Coverage Survey. Am J Trop Med Hyg 2015 Jun 8;15-198.
21. World Health Organization. Immunization coverage cluster survey-Reference manual. Geneva: WHO Document Production Services; 2005 Jun.
22. Sow SO, Tapia MD, Diallo S, Keita MM, Sylla M, Onwuchekwa U, et al. Haemophilus influenzae type b conjugate vaccine introduction in Mali: Impact on disease burden and serologic correlate of protection. Am J Trop Med Hyg 2009; 80(6):1033-8. PMID: 19478272.
23. Fadnes LT, Nankabirwa V, Sommerfelt H, Tylleskar T, Tumwine JK, Engebretsen IM. Is vaccination coverage a good indicator of age-appropriate vaccination? A prospective study from Uganda. Vaccine 2011 Apr 27; 29(19):3564-70. doi:10.1016/j.vaccine.2011.02.093 PMID: 21402043.
24. Babirye JN, Engebretsen IM, Makumbi F, Fadnes LT, Wamani H, Tylleskar T, et al. Timeliness of childhood vaccinations in Kampala Uganda: a community-based cross-sectional study. PLoS ONE 2012; 7 (4):e35432. doi:10.1371/journal.pone.0035432 PMID: 22539972.
25. Tapia MD, Pasetti MF, Cuberos L, Sow SO, Doumbia MN, Bagayogo M, et al. Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys. Pediatr Infect Dis J 2006 Sep; 25(9):819-25. PMID: 16940841.
26. Simonsen O, Bentzon MW, Heron I. ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand 1986 Jul; 14(3):231-9. PMID: 3759998.
27. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995 Mar 23; 332(12):761-6. PMID: 7862178.
28. Hayney MS, Love GD, Carlberg BM, Buck JM, Muller D. Tetanus seroprevalence among farmers: a preliminary study. J Rural Health 2003; 19(2):109-12. PMID: 12696846.
29. Redwan E, Al-Awady MK. Prevalence of tetanus immunity in the Egyptian population. Hum Antibodies 2002; 11(1-2):55-9. PMID: 12237476.
30. Yuan L, Lau W, Thipphawong J, Kasenda M, Xie F, Bevilacqua J. Diphtheria and tetanus immunity among blood donors in Toronto. CMAJ 1997 Apr 1; 156(7):985-90. PMID: 9099166.
31. Lim SS, Stein DB, Charrow A, Murray CJ. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage. Lancet 2008 Dec 13; 372(9655):2031-46. doi:10.1016/S0140-6736(08)61869-3 PMID: 19070738.
32. Miles M, Ryman TK, Dietz V, Zell E, Luman ET. Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature. Vaccine 2013 Mar 15; 31(12):1560-8. doi:10.1016/j.vaccine.2012.10.089PMID: 23196207.
33. Preziosi MP, Yam A, Wassilak SG, Chabirand L, Simaga A, Ndiaye M, et al. Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program. Am J Epidemiol 2002 May 15; 155(10):891-6. PMID: 11994227.
34. Sow SO, Diallo S, Campbell JD, Tapia MD, Keita T, Keita MM, et al. Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine. Pediatr Infect Dis J 2005 Jun; 24(6):533-7. PMID: 15933564.
35. Campagne G, Garba A, Schuchat A, Boulanger D, Plikaytis BD, Ousseini M, et al. Response to conjugate Haemophilus influenzae B vaccine among infants in Niamey, Niger. Am J Trop Med Hyg 1998 Nov; 59(5):837-42. PMID: 9840608.
36. Clark A, Sanderson C. Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet 2009 May 2; 373(9674):1543-9. doi:10.1016/S0140-6736(09)60317-2 PMID: 19303633.
37. Deming MS, Roungou JB, Kristiansen M, Heron I, Yango A, Guenengafo A, et al. Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus. Bull World Health Organ 2002; 80(9):696-703. PMID: 12378286.
38. Hayford KT, Shomik MS, Al-Emran HM, Moss WJ, Bishai D, Levine OS. Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study. BMC Public Health 2013 Dec;%20; 13:1211. doi:10.1186/1471-2458-13-1211.:1211-3 PMID: 24359402.
39. Riddell MA, Byrnes GB, Leydon JA, Kelly HA. Dried venous blood samples for the detection and quantification of measles IgG using a commercial enzyme immunoassay. Bull World Health Organ 2003; 81 (10):701-7. PMID: 14758429.
40. Colson KE, Potter A, Conde-Glez C, Hernandez B, Rios-Zertuche D, Zuniga-Brenes P, et al. Use of a commercial ELISA for the detection of measles-specific immunoglobulin G (IgG) in dried blood spots collected from children living in low-resource settings. J Med Virol 2015 Sep; 87(9):1491-9. doi:10.1002/jmv.24136 PMID:25988945.
41. Nokes DJ, Enquselassie F, Nigatu W, Vyse AJ, Cohen BJ, Brown DW, et al. Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull World Health Organ 2001; 79(7):588-95. PMID: 11477961.
42. Ohuma EO, Okiro EA, Bett A, Abwao J, Were S, Samuel D, et al. Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models. Epidemiol Infect 2009 Feb; 137(2):227-33. doi:10.1017/S0950268808000848 PMID: 18544176.
43. Nigatu W, Samuel D, Cohen B, Cumberland P, Lemma E, Brown DW, et al. Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys. Vaccine 2008 Sep 2; 26(37):4769-74. doi:10.1016/j.vaccine.2008.07.005 PMID: 18644417.